Is PolyPid Stock a Good Investment?

PolyPid Investment Advice

PYPD

To provide specific investment advice or recommendations on PolyPid stock, we recommend investors consider the following general factors when evaluating PolyPid. This will help you to make an informed decision on whether to include PolyPid in one of your diversified portfolios:

Examine PolyPid's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research PolyPid's leadership team and their track record. Good management can help PolyPid navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact PolyPid's business and its evolving consumer preferences.
Compare PolyPid's performance and market position to its competitors. Analyze how PolyPid is positioned in terms of product offerings, innovation, and market share.
Check if PolyPid pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about PolyPid's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in PolyPid stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if PolyPid is a good investment.

Sell

Buy

Strong Sell

We provide trade recommendations to complement the recent expert consensus on PolyPid. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure PolyPid is not overpriced, please check all PolyPid fundamentals, including its cash flow from operations, and the relationship between the cash per share and beta . Given that PolyPid has a number of shares shorted of 13.01 K, we recommend you to check out PolyPid market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance	Very Weak	Details
Volatility	Somewhat reliable	Details
Hype Condition	Stale	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Almost neglects market trends	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Frail	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine PolyPid Stock

Researching PolyPid's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 7.22. PolyPid had not issued any dividends in recent years. The entity had 1:30 split on the 21st of September 2023.

To determine if PolyPid is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PolyPid's research are outlined below:

	PolyPid had very high historical volatility over the last 90 days
	PolyPid has a very high chance of going through financial distress in the upcoming years
	Net Loss for the year was (23.86 M) with profit before overhead, payroll, taxes, and interest of 0.
	PolyPid currently holds about 23.78 M in cash with (17.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
	PolyPid has a frail financial position based on the latest SEC disclosures
	Roughly 24.0% of the company outstanding shares are owned by corporate insiders
	Latest headline from seekingalpha.com: PolyPid reports 9M results

PolyPid Quarterly Cash And Short Term Investments

9.53 Million

PolyPid uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PolyPid. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PolyPid's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	14th of February 2024 Upcoming Quarterly Report	View
	8th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	14th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact PolyPid's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises PolyPid's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2020-11-11	2020-09-30	-0.39	-0.35	0.04	10
2022-11-09	2022-09-30	-0.54	-0.48	0.06	11
2023-02-08	2022-12-31	-0.41	-0.32	0.09	21
2021-11-10	2021-09-30	-0.62	-0.53	0.09	14
2021-02-10	2020-12-31	-0.51	-0.41	0.1	19
2022-02-09	2021-12-31	-0.56	-0.71	-0.15	26
2023-08-09	2023-06-30	-0.31	-0.13	0.18	58
2024-11-13	2024-09-30	-1.02	-1.22	-0.2	19

Know PolyPid's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as PolyPid is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PolyPid backward and forwards among themselves. PolyPid's institutional investor refers to the entity that pools money to purchase PolyPid's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Aigh Capital Management, Llc	2024-09-30	679.7 K
Rosalind Advisors, Inc.	2024-09-30	679.2 K
Dafna Capital Management Llc	2024-09-30	308.5 K
Adar1 Capital Management Llc	2024-09-30	93.9 K
Yelin Lapidot Holdings Management Ltd	2024-06-30	11.2 K
Steward Partners Investment Advisory, Llc	2024-06-30	7.3 K
Ubs Group Ag	2024-06-30	2.4 K
Morgan Stanley - Brokerage Accounts	2024-06-30	1.8 K
Advisor Group Holdings, Inc.	2024-06-30	467
Golden State Equity Partners	2024-09-30	90.0

Note, although PolyPid's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PolyPid's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.51 M.

Market Cap

10.39 Million

PolyPid's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(1.55)	(1.63)
Return On Capital Employed	(2.83)	(2.97)
Return On Assets	(1.55)	(1.63)
Return On Equity	11.39	11.96

Determining PolyPid's profitability involves analyzing its financial statements and using various financial metrics to determine if PolyPid is a good buy. For example, gross profit margin measures PolyPid's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PolyPid's profitability and make more informed investment decisions.

Please note, the presentation of PolyPid's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PolyPid's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PolyPid's management manipulating its earnings.

Evaluate PolyPid's management efficiency

PolyPid has return on total asset (ROA) of (0.6465) % which means that it has lost $0.6465 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.9662) %, meaning that it created substantial loss on money invested by shareholders. PolyPid's management efficiency ratios could be used to measure how well PolyPid manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 11.96, whereas Return On Tangible Assets are forecasted to decline to (1.63). At present, PolyPid's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 7 M, whereas Non Currrent Assets Other are forecasted to decline to about 82.7 K.

	Last Reported	Projected for Next Year
Book Value Per Share	(1.49)	(1.57)
Tangible Book Value Per Share	(1.49)	(1.57)
Enterprise Value Over EBITDA	(0.57)	(0.60)
Price Book Value Ratio	(2.55)	(2.67)
Enterprise Value Multiple	(0.57)	(0.60)
Price Fair Value	(2.55)	(2.67)
Enterprise Value	11.5 M	16.6 M

Effective leadership at PolyPid drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.

Beta

1.316

Basic technical analysis of PolyPid Stock

As of the 30th of November, PolyPid holds the Coefficient Of Variation of 9027.0, semi deviation of 3.18, and Risk Adjusted Performance of 0.0163. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PolyPid, as well as the relationship between them. Please check PolyPid standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if PolyPid is priced some-what accurately, providing market reflects its current price of 3.34 per share. Given that PolyPid has jensen alpha of 0.0643, we recommend you to check out PolyPid's recent market performance to make sure the company can sustain itself at a future point.

PolyPid's Outstanding Corporate Bonds

PolyPid issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PolyPid uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PolyPid bonds can be classified according to their maturity, which is the date when PolyPid has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	Volcan Compania Minera Corp Bond USP98047AC08	View
	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	International Game Technology Corp Bond US460599AD57	View
	Morgan Stanley 3591 Corp Bond US61744YAK47	View
	MGM Resorts International Corp Bond US552953CD18	View

View All PolyPid Corporate Bonds

Understand PolyPid's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing PolyPid's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0163
	Market Risk Adjusted Performance	(0.1)
	Mean Deviation	2.41
	Semi Deviation	3.18
	Downside Deviation	3.6
	Coefficient Of Variation	9027.0
	Standard Deviation	3.52
	Variance	12.41
	Information Ratio	(0.03)
	Jensen Alpha	0.0643
	Total Risk Alpha	(0.56)
	Sortino Ratio	(0.03)
	Treynor Ratio	(0.11)
	Maximum Drawdown	23.57
	Value At Risk	(4.97)
	Potential Upside	4.66
	Downside Variance	12.98
	Semi Variance	10.13
	Expected Short fall	(2.88)
	Skewness	0.3917
	Kurtosis	3.65

	Risk Adjusted Performance	0.0163
	Market Risk Adjusted Performance	(0.1)
	Mean Deviation	2.41
	Semi Deviation	3.18
	Downside Deviation	3.6
	Coefficient Of Variation	9027.0
	Standard Deviation	3.52
	Variance	12.41
	Information Ratio	(0.03)
	Jensen Alpha	0.0643
	Total Risk Alpha	(0.56)
	Sortino Ratio	(0.03)
	Treynor Ratio	(0.11)
	Maximum Drawdown	23.57
	Value At Risk	(4.97)
	Potential Upside	4.66
	Downside Variance	12.98
	Semi Variance	10.13
	Expected Short fall	(2.88)
	Skewness	0.3917
	Kurtosis	3.65

Consider PolyPid's intraday indicators

PolyPid intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PolyPid stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	416.52
	Daily Balance Of Power	(0.71)
	Rate Of Daily Change	0.97
	Day Median Price	3.43
	Day Typical Price	3.4
	Price Action Indicator	(0.15)
	Period Momentum Indicator	(0.12)
	Relative Strength Index	57.61

PolyPid Corporate Filings

6K	29th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
13A	28th of October 2024 An amended filing to the original Schedule 13G	View Verify
	30th of August 2024 Other Reports	View Verify
	12th of August 2024 Other Reports	View Verify

PolyPid time-series forecasting models is one of many PolyPid's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PolyPid's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

PolyPid Stock media impact

Far too much social signal, news, headlines, and media speculation about PolyPid that are available to investors today. That information is available publicly through PolyPid media outlets and privately through word of mouth or via PolyPid internal channels. However, regardless of the origin, that massive amount of PolyPid data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of PolyPid news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of PolyPid relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to PolyPid's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive PolyPid alpha.

PolyPid Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards PolyPid can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

PolyPid Corporate Management

Ori Warshavsky	Chief US	Profile
Dikla Akselbrad	Chief Officer	Profile
Malka Reichart	Scientific Director	Profile
Rivi Levari	Vice Resource	Profile
Orna Blum	Legal Counsel	Profile
JeanMarc PharmD	Chief Officer	Profile
Tal Vilnai	General Secretary	Profile

When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports: